NEWS

Back
Title

AIDOT participated in the 1st INASMEET International Academic Event in Indonesia

Posted by aidot(ip:)

Date 2022-11-28

View 32

Rate 0점  

Recommend Recommend this

Message

Aidot participates in the 1st INASMEET international academic event in Indonesia

(Professor Jae-yun Song of Korea University Anam Hospital presented the effectiveness of AI-based cervical cancer screening)




[View original text]



AIDOT (CEO Jae-hoon Jeong), a company specializing in medical artificial intelligence (AI) solutions, announced that it had participated in the 1st INASMEET (The 1st Indonesian 

Society Gynecologic Oncology Scientific Meeting) international academic event.

 

The 1st INASMEET, which was held at The Stones Hotel in Bali, Indonesia for two days from 12th~13th of November, is an international academic event in which Indonesian and 

foreign gynecologists participate and exchange information on academic achievements and the latest international trends.

 

AIDOT attended this event with its local partner, PT Pyridam Farma to showcase Cerviray products, and on the 12th, had the General Gynecologist & General Practitioner Session, 

Professor Jae-yun Song of the Department of Obstetrics and Gynecology at Korea University Anam Hospital presented 'Cervical Cancer Screening with VIA and AI.' He introduced the 

effectiveness of Cerviray and a combination of VIA and artificial intelligence.

 

Then, Professor Tofan Widya Utami and Professor Laila Nuranna of the RSCM Hospital in Indonesia presented Cerviray as a method for cervical cancer screening in Indonesia under 

the themes of 'The Challenge of Cervical Cancer Elimination by 2030 in Indonesia' and 'Cerviray Session', respectively. It received a great response from medical staff.

 

Jaehoon Jeong, CEO of AIDOT, said, “Cerviray has received many local medical staff’s expectations and interest as it will open a new era as Indonesia’s next-generation cervical cancer screening system.” We will continue to develop solutions that help make accurate diagnoses.”

 

Meanwhile, on 7th of November, AIDOT's 'Global Commercialization of Cervical Cancer Diagnosis System based on Artificial Intelligence' was selected as one of the 100 national R&D excellence achievements in 2022.

 

Overview of AIDOT Inc.

 

Since its foundation in June 2014, AIDOT has been recognized for its technological prowess, including being selected for KIC China and various government projects. In addition, an 

artificial intelligence-based reading system combining carotid ultrasound and genomic information was jointly developed with Hallym University Chuncheon Sacred Heart Hospital's 

Department of Neurosurgery, and a digestive AI diagnosis system that integrated gastroscopy, capsule endoscopy, and colonoscopy was also completed.

 

Korea News Association / 28th. Nov. 2022.



Attachment news.jpg

Password
Edit

Please enter password to remove or edit this post.

Comments

There are no comments to display.

Edit Comment

Name

Password

Message

/ byte

Edit Cancel
Password :
OK Cancel
Add Comment

Name

Password

Combination in 10-16 characters containing at least two of the followings: upper and lower case letters/numbers/special letters

Message

/ byte

Rate

Please type without any spaces.

Comments can be added by Member only.

WORLD SHIPPING

PLEASE SELECT THE DESTINATION COUNTRY AND LANGUAGE :

GO
닫기